期刊文献+

2型糖尿病对鼠缺血性卒中的影响 被引量:5

Effect of type 2 diabetes on middle cerebral artery occlusion-induced focal cerebral ischemia
原文传递
导出
摘要 目的 研究2型糖尿病大鼠诱导血管内皮生长因子(VEGF)和血管增生作用及其在大脑中动脉局灶性脑缺血后对梗死体积、梗死后出血的影响.方法 诱导制备2型糖尿病大鼠,糖尿病大鼠与正常血糖鼠均采用线栓法制备大脑中动脉局灶性脑缺血模型.应用墨汁灌注脑血管法观察脑内血管,2,3,5-三苯四氮唑(TTC)染色法检测梗死体积,免疫组织化学方法 检测VEGF与CD34的表达.结果 墨汁灌注脑血管后在糖尿病组可见细小血管明显增生.TTC染色见糖尿病组梗死局限在皮质下,成蚕豆样,正常血糖组梗死相对弥散,广泛累及皮质,且糖尿病组梗死体积[(80.07±11.21)mm3]明显小于正常血糖组[(98.91±14.86)mm3],差异具有统计学意义(t=2.48,P=0.0326).糖尿病组可见明确的梗死后出血.免疫组织化学结果 显示VEGF与CD34的表达在糖尿病组明显高于正常血糖组,且差异均具有统计学意义.结论 糖尿病脑缺血性梗死后VEGF与CD34表达高于正常血糖组.糖尿病可明显诱导脑血管扭曲、重构及新生.这些病理性血管在脑缺血后可能会减小梗死体积但加重梗死后出血而影响预后. Objective To study the function of vascular endothelial growth factor (VEGF) in type 2 diabetes model rats and its effect on focal cerebral ischemia induced by middle cerebral artel7 occlusion in these rats. Methods Focal cerebral ischemia was induced by middle cerebral artery occlusion for 6 hours in type 2 diabetes rats and normal control rats. Blood vessels morphology was examined by ink perfusion, infarct size was measured by TTC and expression of VEGF and CD34 were evaluated by immunohistochemistry staining. Results Ink perfusion revealed increased number of small vessels in type 2 diabetes rats. Infarct size was significantly smaller in type 2 diabetes rats ( (80. 07 -+ 11.21 )mm3 ) than that in normal controls ((98.91 -+ 14. 86) mm3, t = 2. 48, P = 0. 0326). There were more hemorrhage lesions in the ischemie hemisphere in type 2 diabetes rats when comparing with the controls. VEGF and CD34 showed significantly higher expression in type 2 diabetes rats than in normal controls. Conclusions High expression of VEGF and CD34 are found in type 2 diabetes rats after middle cerebral artery occlusion. There is cerebrolvascular remodeling in diabetes rats. While this diabetes-induced remodeling appears to prevent infarct expansion, the changes also increase the risk of hemorrhagic transformation. The latter may result in poor prognosis.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2011年第4期238-241,共4页 Chinese Journal of Neurology
基金 国家自然科学基金资助项目(30973106)
关键词 糖尿病 2型 脑缺血 脑梗死 血管内皮生长因子A 抗原 CD34 大鼠 Diabetes mellitus, type 2 Brain isehemia Brain infarction Vascular endothelial growth factor A Antigens, CD34 Rats
  • 相关文献

参考文献17

  • 1Mellado TP,Court LJ,Godoy FJ,et al.Cerebrovascular disease in a Neurologic Intermediate Care Unit in Chile.Analysis of 459 consecutive patients.Rev Med Chil,2005,133:1274-1284.
  • 2Cavallini A,Micieli G,Marcheselli S,et al.Role of monitoring in management of acute ischemic stroke patients.Stroke,2003,34:2599-2603.
  • 3Ginsberg MD.Hyperglycemia and stroke outcome:vindication of the ischemic penumbra.Ann Neurol,2002,52:20-28.
  • 4黄贤德,郭利君,颜东文,张菊兰,史葆光,陈一戎.糖尿病增加前列腺增生患者血尿发生率[J].基础医学与临床,2005,25(10):930-933. 被引量:11
  • 5苗勤,孙乐羽,牛延良,姜炎.生长因子在糖尿病大鼠脑缺血再灌注中的表达[J].中国实用神经疾病杂志,2008,11(3):17-19. 被引量:2
  • 6田有勇,孙圣刚,汤翠菊,王岚,张振涛,乔娴,陈小武.血管内皮生长因子通过神经纤毛蛋白-1受体防护6-羟基多巴胺诱导的PC12细胞损伤[J].中华神经科杂志,2006,39(6):369-373. 被引量:2
  • 7Bruno A,Levine SR,Frankel MR,et al.Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.Neurology,2002,59:669-674.
  • 8Bruno A,Biller J,Adams HP Jr,et al.Acute blood glucose level and outcome from ischemic stroke.Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.Neurology,1999,52:280-284.
  • 9Martini SR,Kent TA.Hyperglycemia in acute ischemic stroke:a vascular perspective.J Cereb Blood Flow Metab,2007,27:435-451.
  • 10Lindsberg PJ,Roine RO.Hyperglycemia in acute stroke.Stroke,2004,35:363-364.

二级参考文献39

  • 1皮全民.糖尿病大鼠视网膜视细胞超微结构的研究[J].菏泽医学专科学校学报,2004,16(4):1-3. 被引量:2
  • 2于德民,吴锐,尹潍,袁咏.实验性链脲佐菌素糖尿病动物模型的研究[J].中国糖尿病杂志,1995,3(2):105-109. 被引量:425
  • 3李华军,李威,邵延坤,饶明俐,朱晓波.大鼠局灶性脑缺血/再灌注后VEGF的变化对缺血脑组织的影响[J].中国老年学杂志,2006,26(9):1229-1230. 被引量:4
  • 4[2]Longa EZ,Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989,20:84-91.
  • 5[3]Zausinger S,Hungerhuber E,Baethmann A,et al.Neurological impairment in rats after transient middle cerebral artery occlusion:a comparative study under various treatment paradigms[J].Brain Res,2000,863(1/2):94-105.
  • 6[4]Hamann GF,Okada Y,Del Zoppo GJ.Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia-reperfusion[J].Cereb Blood Flow Metab,1996,16 (6):1373-1378.
  • 7[6]Yang ZJ,Bao WL,Qiu MH,et al.Role of vascular endothelial growth factor in neuronal DNA damage and repair in rat brain following a transient cerebral ischemia[J].J Neurosci Res,2002,70:140-149.
  • 8[7]Manoonkitiwongsa PS,Schuhz RL,Mc Creery DB,et al.Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis[J].J Cereb Blood Flow Metab,2004,24(6):693-702.
  • 9谢学军,李瑞荃,廖品正,张发荣.糖尿病大鼠视神经病理学研究——光镜与电镜观察[J].眼科研究,1997,15(1):23-25. 被引量:15
  • 10Ylikorkala A,Rossi DJ,Korsisaari N,et al.Vascular Abnormalities and Deregulation of VEGF in Lkbl-Deficient Mice.Science,2001,293:1323-1326.

共引文献32

同被引文献73

  • 1张慧,闫咏梅.糖尿病性与非糖尿病性脑梗死中医证候及CT特点的对比观察[J].陕西中医,2008,29(2):174-176. 被引量:10
  • 2陈名道.波动性高血糖与糖尿病并发症[J].国际内分泌代谢杂志,2006,26(5):312-314. 被引量:96
  • 3尤卫平,严丽英,王江南,杨明峰,张颜波,李丰衣.糖尿病性脑梗死大鼠模型的建立[J].实用糖尿病杂志,2007,3(4):24-26. 被引量:1
  • 4Cefalu WT. Animal models of type 2 diabetes:Clinical presentation and pathophysiological relevance to the human condition[J]. ILAR J,2006,47(3) :186 - 198.
  • 5Srinivasan K, Viswanad B, Asrat L, et al. Combination of high - fat diet - fed and low - dose streptozotoein - treated rat,. A model for type 2 diabetes and pharmacological screening[J]. Pharmacol Res, 2005,52(4) :313 - 320.
  • 6Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cere- bral artery occlusion without craniectomy in rats[J]. Stroke, 1989, 20(1) :84 - 91.
  • 7Bederson JB, Pitts LH,Tsuji M,et al. Rat middle cerebral artery occlusion:Evaluation of the model and development of a neurologic examination[J]. Stroke, 1986,17(3):472 -476.
  • 8Li FY, Cheng KK, Lam KS, et al. Cross-talk between adipose tissue and vaseulature : role of adiponectin. Acta Physiol ( Oxf), 2011,203 : 167-180.
  • 9Pan W, Kastin AJ. Adipokines and the blood-brain barrier. Peptides, 2007, 28 : 1317-1330.
  • 10Nortbeott JM, Yeganeh A, Taylor CG, et al. Adipokines and the cardiovascular system: mechanisms mediating health and disease. Can J Physiol Pbarmacol, 2012, 90: 1029-1059.

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部